XML 17 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Awards and Private Placement Investment (Details Textual) (USD $)
1 Months Ended 9 Months Ended
Oct. 31, 2012
Aug. 31, 2012
Jun. 30, 2012
Oct. 31, 2012
Oct. 31, 2011
Nov. 19, 2012
Oct. 19, 2012
Aug. 16, 2012
Jan. 31, 2012
Equity Awards (Textual) [Abstract]                  
Allocated Share-based Compensation Expense         $ 48,000        
Granted restricted shares of common stock       137,325 110,412        
Weighted average fair value with restriction period lapse          $ 1.92        
Convertible note face amount               3,877,000  
New issuance of series A convertible preferred stock               2,416,785  
Conversion share price               $ 3.00  
Exercise price 3.99 4.07   3.99   4.06   3.99  
Weighted average exercise price       $ 3.08 $ 1.90        
Fair value Allocation discount to the preferred shares               1,020,000  
Warrants issued 200,000                
Warrants grant date fair value             754,000    
Maximum Warrants exercisable period       5 years          
Equity Awards (Additional Textual) [Abstract]                  
Common shares issued for convertible note and accrued interest   1,583,220 1,529,729            
Placement and other advisor fees   1,894,000              
Cost of warrants issued   754,000              
Deferred financing cost, net 1,211,912     1,211,912       611,000 145,857
Issuance of common stock warrants   263,000   2,441,852          
Initial issuance price               $ 3.00  
Net of transaction costs, allocated to the warrants   1,425,000              
Warrants fair value disclosure 4,139,000     4,139,000          
Equity investment with Great Point Partners, LLC, and Noro-Moseley Partners               12,000,000  
Warrants exercisable               1,200,000  
Granted options       762,500 1,104,000        
Options expired       258,271 127,916        
Average exercise price       $ 1.87 $ 1.88        
Options exercised under all plans       43,999 32,958        
Granted restricted shares weighted average fair value       $ 2.01 $ 1.68        
Granted restricted shares with restriction period lapse          223,090        
Restriction period       1 year          
Authorized common stock 25,000,000     25,000,000         25,000,000
Common stock, par value $ 0.01     $ 0.01         $ 0.01
Common stock, shares issued 12,582,598     12,582,598         12,582,598
Common stock, shares outstanding 10,433,716     10,433,716         10,433,716
2005 Incentive Stock Option Plan [Member]
                 
Equity Awards (Textual) [Abstract]                  
Additional shares       500,000          
Convertible subordinated notes payable [Member]
                 
Equity Awards (Textual) [Abstract]                  
Convertible note face amount               5,699,577  
Restricted Stock Executive Inducement Grants [Member]
                 
Equity Awards (Textual) [Abstract]                  
Granted restricted shares of common stock         25,000        
Weighted average fair value with restriction period lapse         $ 1.91        
Series A Preferred Stock [Member]
                 
Equity Awards (Textual) [Abstract]                  
Percentage of redeemable convertible preferred stock   0.00%              
New issuance of series A convertible preferred stock               2,416,785  
Preferred Stock price per share               $ 3.00  
Conversion share price $ 8.00     $ 8.00          
Average daily trading volume for period       100,000          
Fair value Allocation discount to the preferred shares 4,410,000     4,410,000          
Recorded beneficial conversion feature amount       2,686,000          
Amortization of deemed dividends in additional paid in capital       $ 139,000          
Preferred stock dividend rate   0.00%